PortfoliosLab logoPortfoliosLab logo
MLTX vs. SOGP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MLTX vs. SOGP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MoonLake Immunotherapeutics (MLTX) and Lizhi Inc (SOGP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MLTX achieves a 44.54% return, which is significantly higher than SOGP's -6.75% return.


MLTX

1D
-3.20%
1M
-0.83%
6M
13.66%
YTD
44.54%
1Y
-64.12%
3Y*
-30.46%
5Y*
13.76%
10Y*
ALL TIME*
11.56%

SOGP

1D
-0.51%
1M
-15.27%
6M
-19.68%
YTD
-6.75%
1Y
125.69%
3Y*
13.24%
5Y*
-27.24%
10Y*
ALL TIME*
-29.41%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MLTX vs. SOGP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
MLTX
MoonLake Immunotherapeutics
44.54%-75.66%-10.33%475.14%6.17%-13.02%11.91%
SOGP
Lizhi Inc
-6.75%465.48%-20.80%-56.51%-65.95%-52.32%71.68%

Correlation

The correlation between MLTX and SOGP is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.05

Correlation (5Y)
Calculated over the trailing 5-year period

0.08

Correlation (All Time)
Calculated using the full available price history since Oct 20, 2020

0.08

Fundamentals

Market Cap

MLTX:

$1.57B

SOGP:

$47.23M

Total Revenue (TTM)

MLTX:

$0.00

SOGP:

CN¥2.07B

Gross Profit (TTM)

MLTX:

-$1.49M

SOGP:

CN¥585.38M

EBITDA (TTM)

MLTX:

-$179.84M

SOGP:

-CN¥138.59M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MLTX vs. SOGP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MLTX
MLTX Risk / Return Rank: 3636
Overall Rank
MLTX Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
MLTX Sortino Ratio Rank: 5151
Sortino Ratio Rank
MLTX Omega Ratio Rank: 6464
Omega Ratio Rank
MLTX Calmar Ratio Rank: 1717
Calmar Ratio Rank
MLTX Martin Ratio Rank: 2525
Martin Ratio Rank

SOGP
SOGP Risk / Return Rank: 8080
Overall Rank
SOGP Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
SOGP Sortino Ratio Rank: 9797
Sortino Ratio Rank
SOGP Omega Ratio Rank: 9595
Omega Ratio Rank
SOGP Calmar Ratio Rank: 7777
Calmar Ratio Rank
SOGP Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MLTX vs. SOGP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MoonLake Immunotherapeutics (MLTX) and Lizhi Inc (SOGP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MLTXSOGPDifference
Sharpe ratioReturn per unit of total volatility

-1.02

Sortino ratioReturn per unit of downside risk

-3.25

Omega ratioGain probability vs. loss probability

1.16

1.46

-0.31

Calmar ratioReturn relative to maximum drawdown

-0.71

1.79

-2.50

Martin ratioReturn relative to average drawdown

-0.95

2.33

-3.29

MLTX vs. SOGP - Sharpe Ratio Comparison

The current MLTX Sharpe Ratio is -0.55, which is lower than the SOGP Sharpe Ratio of 0.47. The chart below compares the historical Sharpe Ratios of MLTX and SOGP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MLTX vs. SOGP - Drawdown Comparison

The maximum MLTX drawdown since its inception was -90.22%, smaller than the maximum SOGP drawdown of -99.25%. Use the drawdown chart below to compare losses from any high point for MLTX and SOGP.


Loading charts...

Drawdown Indicators


MLTXSOGPDifference

Max Drawdown

Largest peak-to-trough decline

-90.22%

-99.25%

+9.03%

Max Drawdown (1Y)

Largest decline over 1 year

-89.93%

-70.70%

-19.23%

Max Drawdown (3Y)

Largest decline over 3 years

-90.22%

-86.52%

-3.70%

Max Drawdown (5Y)

Largest decline over 5 years

-90.22%

-97.76%

+7.54%

Current Drawdown

Current decline from peak

-70.17%

-92.77%

+22.60%

Average Drawdown

Average peak-to-trough decline

-30.00%

-84.45%

+54.45%

Ulcer Index

Depth and duration of drawdowns from previous peaks

67.21%

54.11%

+13.10%

Volatility

MLTX vs. SOGP - Volatility Comparison

MoonLake Immunotherapeutics (MLTX) and Lizhi Inc (SOGP) have volatilities of 19.57% and 18.83%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MLTXSOGPDifference

Volatility (1M)

Calculated over the trailing 1-month period

19.57%

18.83%

+0.74%

Volatility (6M)

Calculated over the trailing 6-month period

42.01%

48.10%

-6.09%

Volatility (1Y)

Calculated over the trailing 1-year period

117.06%

269.77%

-152.71%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

91.65%

156.40%

-64.75%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

86.03%

159.50%

-73.47%

Dividends

MLTX vs. SOGP - Dividend Comparison

MLTX has not paid dividends to shareholders, while SOGP's dividend yield for the trailing twelve months is around 21.91%.


PositionTTM2025
MLTX
MoonLake Immunotherapeutics
0.00%0.00%
SOGP
Lizhi Inc
21.91%8.61%

Financials

MLTX vs. SOGP - Financials Comparison

This section allows you to compare key financial metrics between MoonLake Immunotherapeutics and Lizhi Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M600.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober20260
422.82M
(MLTX) Total Revenue
(SOGP) Total Revenue
Please note, different currencies. MLTX values in USD, SOGP values in CNY

Frequently Asked Questions


MLTX and SOGP have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MLTX has higher volatility (19.57%) compared to SOGP (18.83%). In terms of maximum drawdown, MLTX dropped -90.22% vs SOGP's -99.25%.

SOGP currently has the higher Sharpe Ratio (0.47 vs -0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MLTX and SOGP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer